接受他汀类药物治疗患者的胆固醇、动脉粥样硬化及炎症风险 - Suppr

Cholesterol, Atherosclerotic, and Inflammatory Risks Among Patients With Statin Therapy.

作者信息

Dai Neng, Hu Yiqing, Tang Xianglin, Guo WeiFeng, Guo Zhenyang, Zhou Fan, Zhang Longjiang, Prakash Edavi Pranav, Lu Hao, Qian Juying, Ge Junbo

出版信息

JACC Cardiovasc Imaging. 2025 Feb;18(2):242-244. doi: 10.1016/j.jcmg.2024.08.009. Epub 2024 Oct 23.

DOI:10.1016/j.jcmg.2024.08.009

PMID:39453354

Abstract

摘要

相似文献

Cholesterol, Atherosclerotic, and Inflammatory Risks Among Patients With Statin Therapy.接受他汀类药物治疗患者的胆固醇、动脉粥样硬化及炎症风险

JACC Cardiovasc Imaging. 2025 Feb;18(2):242-244. doi: 10.1016/j.jcmg.2024.08.009. Epub 2024 Oct 23.

Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy.通过饮食调整和他汀类药物治疗解决动脉粥样硬化斑块中的细胞凋亡问题。

J Nucl Med. 2005 Dec;46(12):2051-6.

Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study.他汀类药物治疗的 2 型糖尿病患者心血管并发症残留风险：台湾糖尿病登记研究。

Lipids Health Dis. 2024 Jan 23;23(1):24. doi: 10.1186/s12944-023-02001-z.

A risk stratification analysis of atherosclerotic cardiovascular disease events post-statin discontinuation in patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass bariatric/metabolic surgeries.袖状胃切除术或 Roux-en-Y 胃旁路减重/代谢手术后他汀类药物停药后发生动脉粥样硬化性心血管疾病事件的风险分层分析。

Surgery. 2024 Sep;176(3):597-604. doi: 10.1016/j.surg.2024.05.024. Epub 2024 Jun 19.

Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis.比较他汀类药物低/中强度联合依折麦布与高强度他汀类药物单药治疗动脉粥样硬化性心血管疾病患者的安全性和疗效：一项更新的荟萃分析。

Am J Cardiovasc Drugs. 2024 May;24(3):419-431. doi: 10.1007/s40256-024-00642-8. Epub 2024 Apr 5.

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial.瑞西伐他汀与依折麦布联合中等强度他汀治疗与高强度他汀单药治疗动脉粥样硬化性心血管疾病患者的长期疗效和安全性（RACING）：一项随机、开放标签、非劣效性试验。

Lancet. 2022 Jul 30;400(10349):380-390. doi: 10.1016/S0140-6736(22)00916-3. Epub 2022 Jul 18.

Alternative LDL Cholesterol-Lowering Strategy vs High-Intensity Statins in Atherosclerotic Cardiovascular Disease: A Systematic Review and Individual Patient Data Meta-Analysis.动脉粥样硬化性心血管疾病中替代低密度脂蛋白胆固醇降低策略与高强度他汀类药物的比较：系统评价和个体患者数据荟萃分析

JAMA Cardiol. 2025 Feb 1;10(2):137-144. doi: 10.1001/jamacardio.2024.3911.

Effect of Statin Therapy on Cardiovascular Outcome in Stroke Patients with Low Baseline Low-Density Lipoprotein Cholesterol.他汀类药物治疗对基线低密度脂蛋白胆固醇水平低的卒中患者心血管结局的影响。

Ann Neurol. 2024 May;95(5):876-885. doi: 10.1002/ana.26895. Epub 2024 Feb 24.

Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial.代谢综合征合并动脉粥样硬化性心血管疾病患者应用中等强度他汀联合依折麦布与高强度他汀单药治疗的疗效比较：RACING 试验事后分析。

Diabetes Obes Metab. 2024 Mar;26(3):829-839. doi: 10.1111/dom.15374. Epub 2023 Nov 23.

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation.他汀类药物/依折麦布联合治疗与他汀类药物单药治疗颈动脉粥样硬化斑块炎症。

Medicine (Baltimore). 2021 Mar 12;100(10):e25114. doi: 10.1097/MD.0000000000025114.

引用本文的文献

Ethnic Differences in Pericoronary Adipose Tissue Attenuation.冠状动脉周围脂肪组织衰减的种族差异。

JACC Asia. 2025 Jan 7;5(1):12-14. doi: 10.1016/j.jacasi.2024.11.015. eCollection 2025 Jan.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cholesterol, Atherosclerotic, and Inflammatory Risks Among Patients With Statin Therapy.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献